US69366J2006
US69366J2006
PTC Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.4B EUR | 6.8B EUR | 5.65B EUR | 6.19B EUR |
Enterprise Value | 6.01B EUR | 6.44B EUR | 5.21B EUR | 7.91B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 27.3x | -- | -- | -- |
Price to Sales | 5.35x | 6.74x | 6.83x | 11.16x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 5.96x | 6.39x | 6.3x | 14.27x |
EV/EBITDA | 35.1x | 39.14x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -5.31% | -4.89% | -9.15% | -7.37% |